Posted in | News | Business | Minerals | Mining

BHP Billiton Complete Acquisition of Athabasca Potash Inc

BHP Billiton Canada Inc. (BHP Billiton) today announced that it has completed the previously announced acquisition, pursuant to a Plan of Arrangement, of all the issued and outstanding common shares of Athabasca Potash Inc (API) for C$8.35 cash per common share.

This acquisition provides BHP Billiton with 100 per cent control of the Burr project and various additional potash exploration properties in Saskatchewan, Canada. BHP Billiton now has access to a total of more than 14,000 km² of prospective exploration ground in the world-class Saskatchewan potash basin.

BHP Billiton also announced that an application to delist API's common shares has been filed with the Toronto Stock Exchange and the delisting is expected to be effective within three trading days of filing. An application has been filed to allow API to cease to be a reporting issuer under applicable Canadian securities laws, and relief is expected to be granted before the end of March.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BHP. (2019, March 18). BHP Billiton Complete Acquisition of Athabasca Potash Inc. AZoM. Retrieved on October 30, 2024 from https://www.azom.com/news.aspx?newsID=21065.

  • MLA

    BHP. "BHP Billiton Complete Acquisition of Athabasca Potash Inc". AZoM. 30 October 2024. <https://www.azom.com/news.aspx?newsID=21065>.

  • Chicago

    BHP. "BHP Billiton Complete Acquisition of Athabasca Potash Inc". AZoM. https://www.azom.com/news.aspx?newsID=21065. (accessed October 30, 2024).

  • Harvard

    BHP. 2019. BHP Billiton Complete Acquisition of Athabasca Potash Inc. AZoM, viewed 30 October 2024, https://www.azom.com/news.aspx?newsID=21065.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.